Effect of ITPKb inhibitors and anti-IL2 antibodies in mo

Project: Research project

Project Details

Description

Effect of ITPKb inhibitors and anti-IL2 antibodies in models of chronic graft vs. host disease
StatusFinished
Effective start/end date7/1/113/31/14

Funding

  • Novartis Pharma AG

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.